BCCDC’s collaborative, trans-disciplinary research programs and projects span all service lines.
We focus on communicable disease threats like hepatitis C virus (HCV), antimicrobial resistance, human immunodeficiency virus (HIV), tuberculosis (TB) influenza, Mpox and COVID-19. Our work also explores roles for public health in mitigating the health effects of climate change, informing injury prevention policies, responding to the toxic drug crisis in our province and pioneering real-time, linked-cohort analysis to guide care and response.
Our researchers employ innovative technologies and methodologies, such as genomics, mathematical modelling and novel epidemiological and statistical tools.
Woven throughout our operations and research is our commitment to acting on Truth and Reconciliation with Indigenous communities and advancing health equity. We recognize this is an ongoing effort that takes continuous collaboration with Indigenous communities, settlers and researchers.
BCCDC’s research programming is designed to respond and adapt to the health care needs of the moment. Our research projects are currently focused across several targeted areas:
- COVID-19 response & recovery
- Overdose emergency response
- Climate change adaptation
- Mental health resiliency
- Emerging hazards preparedness
- Indigenous health promotion
- Chronic disease prevention
- Public health genomics
- Advancing data science
- 2R2: Higher Dose Rifampin for 2 months vs Standard Dose. Project lead: Dr. James Johnston
- A precision public health approach to eliminating TB transmission. Project lead: Dr. James Johnston
- A randomized trial of doxycycline chemoprophylaxis for the prevention of sexually transmitted infections in gay, bisexual and other men who have sex with men (gbMSM). Project lead: Dr. Troy Grennan
- Addressing key knowledge gaps in testing to inform STI prevention & control strategies. Project lead: Dr. Mark Gilbert
- APHC research allowance: Improving the equity, appropriateness and sustainability of sexually-transmitted and blood-borne infection testing systems through implementation science research. Project lead: Dr. Mark Gilbert
- Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation - Theme 2 monitoring the cascade of care. Project lead: Dr. Naveed Janjua
- CTN core co-lead of the co-infections and related conditions (CRC) core. Project lead: Dr. Troy Grennan
- Discourse on COVID-19 and illicit drug toxicity on social media. Project lead: Dr. Naveed Janjua
- Enhanced wastewater surveillance to support safe restart in British Columbia. Project lead: Dr. Natalie Prystajecky
- Estimating the value and long-term impact of implementing risk mitigation guidance to reduce the harms of substance use disorders during the COVID-19 pandemic: a simulation modelling analysis. Project lead: Dr. Amanda Slaunwhite
- Evaluating Prescribed Safer Supply Among Formerly Incarcerated Persons During an Overdose Public Health Emergency. Project lead: Dr. Amanda Slaunwhite
- Evaluating the differential impact of what we have done, as we prioritize what to do next: a multi-provincial intervention modelling study using population-based data. Project lead: Dr. Naveed Janjua
- Host immune responses to Chlamydia Trachomatis candidate vaccine antigens and their association with clinical correlates of protective immunity in women. Project lead: Dr. Robert Brunham
- Impact of COVID-19 pandemic on diabetes care among South Asian population. Project Lead: Dr. Geoffrey McKee
- Improving the equity, appropriateness and sustainability of sexually-transmitted and blood-borne infection testing systems through implementation science research. Project lead: Dr. Mark Gilbert
- Opioid prescribing evaluation & research activities (OPERA). Project lead: Dr. Jane Buxton
- Predicting and evaluating anal cancer in HIV with novel biomarkers: the PEACH study. Project lead: Dr. Troy Grennan
- PeptAid antimicrobial peptides to replace antibiotics in farm veterinary practice. Project leads: Dr. Erin Fraser and Dr. Linda Hoang
- Preventing Opioid Deaths due to COVID Related Increase in Smoking Illicit Substances (Preventing OD CRISIS). Project lead: Dr. Jessica Moe
- RAPID-mNGS - Rapid Agnostic Pathogen Identification Using Metagenomic Next-Generation Sequencing. Project Lead: Dr. Amee Manges
- Role of early childhood viral infection on the development of childhood sleep disordered breathing. Project lead: Dr. Agatha Jassem
- Tacking the 2 greatest obstacles to TB elimination. Project lead: Dr. Victoria Cook
- Teasing apart the differential impact of variants of concern on COVID-19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia. Project lead: Dr. Hind Sbihi
- The DISCO study: rethinking STI prevention. Project lead: Dr. Troy Grennan
- The effects of in utero and neonatal wildfire smoke exposure on birth outcomes and health in early life. Project lead: Dr. Sarah Henderson
- The impact of COVID-19 and related control measures on the hepatitis C virus care cascade. Project lead: Dr. Naveed Janjua
- Treadwell Canada: COVID-19 Vaccine Alliance. Project lead: Dr. Robert Brunham
- Understanding contextual factors to scale up GetCheckedOnline. Project lead: Dr. Mark Gilbert
- Unified pathogen control one health approach specifically targeting norovirus (UPCOAST-N). Project lead: Dr. Natalie Prystajecky
- Unified pathogen control one health approach specifically targeting vibrio (UPCOAST-V). Project lead: Dr. Linda Hoang
